UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
August 7, 2006
Date of Report (date of earliest event reported)
CUTERA, INC.
(Exact name of Registrant as specified in its charter)
Delaware | 000-50644 | 77-0492262 | ||
(State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer | ||
incorporation or organization) | Identification Number) |
3240 Bayshore Blvd.
Brisbane, California 94005
(Address of principal executive offices)
(415) 657-5500
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition.
On August 7, 2006, we are issuing a press release and holding a conference call regarding our financial results for the second quarter of fiscal year 2006 ended June 30, 2006. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K.
This information shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) | Exhibits. |
Exhibit No. | Description | |
99.1 | Press Release of Cutera, Inc. dated as of August 7, 2006. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CUTERA, INC. | ||||
Date: August 7, 2006 | By: | /s/ Kevin P. Connors | ||
Kevin P. Connors | ||||
President and Chief Executive Officer |
Exhibit 99.1
FOR IMMEDIATE RELEASE
CONTACTS:
Cutera, Inc.
Ron Santilli
Chief Financial Officer
415-657-5500
Investor Relations
John Mills
Integrated Corporate Relations, Inc.
310-954-1105
john.mills@icrinc.com
Cutera® Reports Second Quarter 2006 Results
Company Sets New Record for Revenue, and Raises Full-year Guidance
BRISBANE, Calif., August 7, 2006 Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other light-based aesthetic systems for practitioners worldwide, today reported financial results for the second quarter and six months ended June 30, 2006. Key financial highlights are as follows:
Second Quarter 2006:
| Revenue increased by $6.8 million, or 39%, to $24.4 million, compared to the second quarter of 2005. |
| GAAP diluted loss per share, which included the patent litigation settlement and stock-based compensation expenses, was $(0.73). Non-GAAP (1) diluted earnings per share was $0.20. |
First Half 2006:
| Revenue increased by $12.4 million, or 38%, to $45.2 million, compared to the first half of 2005. |
| Diluted loss per share, which included the patent litigation settlement and stock-based compensation expenses, was $(0.64). Non-GAAP(1) diluted earnings per share was $0.33. |
We are very pleased with our second quarter revenue growth, which exceeded our expectations and, we believe, outpaced the overall strong growth in our industry, said Kevin Connors, President and Chief Executive Officer. These results reflect the positive reception our products have been receiving in the marketplace and the investments we have been making in expanding and improving our sales force.
Our financial position remains very strong with $82.0 million of cash and marketable investments- and no debt - enabling us to make additional investments in new product development and sales force expansion, added Mr. Connors. We expect to continue improving the financial leverage in our operating expenses. And with the patent litigation behind us, we are very excited that our management efforts during the second half of 2006 will be focused sharply on expanding our market share and taking advantage of the long-term growth opportunities in light-based aesthetic systems.
Guidance:
Management believes that revenue for the third quarter and full year of 2006 will be approximately $25.0 million and $100 million, respectively. GAAP diluted earnings per share for the third quarter and full year of 2006 are expected to be $0.21 (Non-GAAP(1) $0.27) and break-even (Non-GAAP(1) $1.00), respectively.
Non-GAAP Presentation:
(1) | Effective January 1, 2006, Cutera adopted Statement of Financial Accounting Standards (SFAS) No. 123(R), which required the Company to recognize compensation expense relating to share-based payment transactions in the Statement of Operations. In June 2006, the Company settled its patent litigation. To supplement the consolidated condensed financial statements presented on a GAAP basis, management has provided Non-GAAP net income and Non-GAAP diluted income per share measures that exclude the impact of the litigation settlement and all stock-based compensation expenses, both net of income taxes. The Company believes that these Non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of the companys ongoing operating results and trends, compared with historical results. This presentation is also consistent with managements internal use of the measure, which it uses to measure the performance of ongoing operating results, against prior periods and against our internally developed targets. A table reconciling the GAAP financial measures to the Non-GAAP measures, is included in the condensed consolidated financial information attached to this release. |
Conference Call
The conference call is scheduled to begin at 2:00 p.m. PDT (5:00 p.m. EDT) on August 7, 2006. The call will be broadcast live over the Internet hosted at the Investor Relations section of the Companys website at www.cutera.com and will be archived online within one hour of its completion. In addition, you may call 800-817-4887 to listen to the live broadcast. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Chief Financial Officer.
A telephonic playback of this call will be available from 5:00 p.m. PDT on August 7, 2006, through 11:59 p.m. PDT on August 21, 2006 by calling 888-203-1112. To access this playback, please enter pass code 4814163.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other light-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable dermatologists, plastic surgeons, gynecologists, primary care physicians and other qualified practitioners to offer safe, effective and non-invasive aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cuteras ability to continue to rapidly grow its business, its ability to successfully expand its market share, as well as Cuteras financial guidance for the third quarter and fiscal year 2006, are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on managements current, preliminary expectations and are subject to risks and uncertainties, which may cause Cuteras actual results to differ materially from the statements contained herein. Cuteras second quarter and six-months ended June 30, 2006 financial performance, as discussed in this release, is preliminary and unaudited, and subject to adjustment. Estimates for the third quarter and fiscal year 2006 financial performance are subject to a number of assumptions regarding the future operation of our business. Further information on potential risk factors that could affect Cuteras business and its financial results are detailed in its most recent 10-K and 10-Q as filed with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.
CUTERA, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(unaudited)
June 30, 2006 |
December 31, 2005 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 1,923 | $ | 5,260 | ||||
Marketable investments |
80,042 | 86,736 | ||||||
Accounts receivable, net |
5,651 | 6,478 | ||||||
Inventory |
6,449 | 5,245 | ||||||
Deferred tax asset |
7,611 | 3,027 | ||||||
Other current assets |
5,661 | 3,728 | ||||||
Total current assets |
107,337 | 110,474 | ||||||
Property and equipment, net |
956 | 1,015 | ||||||
Intangibles, net |
1,536 | 469 | ||||||
Total assets |
$ | 109,829 | $ | 111,958 | ||||
Liabilities and Stockholders' Equity |
||||||||
Liabilities: |
||||||||
Accounts payable |
$ | 1,316 | $ | 1,352 | ||||
Accrued liabilities |
10,410 | 9,131 | ||||||
Deferred revenue |
2,637 | 1,673 | ||||||
Total current liabilities |
14,363 | 12,156 | ||||||
Deferred rent |
1,260 | 1,096 | ||||||
Deferred revenue, net of current portion |
1,743 | 1,469 | ||||||
Deferred tax liability |
60 | 60 | ||||||
Total liabilities |
17,426 | 14,781 | ||||||
Stockholders equity: |
||||||||
Common stock |
13 | 12 | ||||||
Additional paid-in capital |
79,369 | 77,705 | ||||||
Deferred stock-based compensation |
(629 | ) | (2,171 | ) | ||||
Retained earnings |
13,801 | 21,743 | ||||||
Accumulated other comprehensive loss |
(151 | ) | (112 | ) | ||||
Total stockholders equity |
92,403 | 97,177 | ||||||
Total liabilities and stockholders equity |
$ | 109,829 | $ | 111,958 | ||||
CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
Three Months Ended June 30, |
Six Months Ended June 30 | |||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||
Net revenue |
$ | 24,395 | $ | 17,570 | $ | 45,152 | $ | 32,717 | ||||||
Cost of revenue |
7,768 | 4,883 | 13,579 | 8,896 | ||||||||||
Gross profit |
16,627 | 12,687 | 31,573 | 23,821 | ||||||||||
Operating expenses: |
||||||||||||||
Sales and marketing |
8,305 | 5,832 | 16,851 | 11,632 | ||||||||||
Research and development |
1,552 | 1,412 | 2,859 | 2,597 | ||||||||||
General and administrative |
4,248 | 2,283 | 8,623 | 4,596 | ||||||||||
Litigation settlement |
18,391 | | 18,391 | | ||||||||||
Total operating expenses |
32,496 | 9,527 | 46,724 | 18,825 | ||||||||||
Income (loss) from operations |
(15,869 | ) | 3,160 | (15,151 | ) | 4,996 | ||||||||
Interest and other income, net |
830 | 516 | 1,786 | 802 | ||||||||||
Income (loss) before income taxes |
(15,039 | ) | 3,676 | (13,365 | ) | 5,798 | ||||||||
Provision (benefit) for income taxes |
(5,990 | ) | 972 | (5,423 | ) | 1,608 | ||||||||
Net income (loss) |
$ | (9,049 | ) | $ | 2,704 | $ | (7,942 | ) | $ | 4,190 | ||||
Net income (loss) per diluted share |
$ | (0.73 | ) | $ | 0.20 | $ | (0.64 | ) | $ | 0.31 | ||||
Weighted-average number of shares used in diluted per share calculations |
12,444 | 13,585 | 12,352 | 13,536 | ||||||||||
CUTERA, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended June 30, |
Six Months Ended June 30, |
|||||||||||||||
2006 | 2005 | 2006 | 2005 | |||||||||||||
Cash flows from operating activities: |
||||||||||||||||
Net income (loss) |
$ | (9,049 | ) | $ | 2,704 | $ | (7,942 | ) | $ | 4,190 | ||||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
||||||||||||||||
Depreciation and amortization |
214 | 157 | 413 | 318 | ||||||||||||
Change in allowance for doubtful accounts |
(87 | ) | (46 | ) | (4 | ) | (85 | ) | ||||||||
Provision for excess and obsolete inventory |
32 | 143 | 32 | 393 | ||||||||||||
Change in deferred taxes |
(4,606 | ) | 6 | (4,584 | ) | 8 | ||||||||||
Stock-based compensation |
911 | 303 | 1,997 | 729 | ||||||||||||
Tax benefit from stock option exercises |
(1,006 | ) | 761 | | 1,314 | |||||||||||
Excess tax benefit related to stock-based compensation expense |
999 | | | | ||||||||||||
Changes in assets and liabilities: |
||||||||||||||||
Accounts receivable |
1,083 | 96 | 831 | 853 | ||||||||||||
Inventory |
203 | (406 | ) | (1,236 | ) | (1,395 | ) | |||||||||
Other current assets |
(1,721 | ) | (444 | ) | (1,933 | ) | (676 | ) | ||||||||
Accounts payable |
(1,071 | ) | 276 | (36 | ) | 48 | ||||||||||
Accrued liabilities |
1,537 | 1,007 | 1,279 | 348 | ||||||||||||
Deferred rent |
82 | 112 | 164 | 224 | ||||||||||||
Deferred revenue |
586 | 211 | 1,238 | 226 | ||||||||||||
Net cash provided by (used in) operating activities |
(11,893 | ) | 4,880 | (9,781 | ) | 6,495 | ||||||||||
Cash flows from investing activities: |
||||||||||||||||
Acquisition of property and equipment |
(137 | ) | (127 | ) | (251 | ) | (257 | ) | ||||||||
Acquisition of intangibles |
(1,170 | ) | | (1,170 | ) | | ||||||||||
Proceeds from sales of marketable investments |
11,021 | 9,500 | 11,460 | 13,450 | ||||||||||||
Proceeds from maturities of marketable investments |
28,717 | 1,000 | 47,405 | 2,010 | ||||||||||||
Purchase of marketable investments |
(27,221 | ) | (19,405 | ) | (52,210 | ) | (24,025 | ) | ||||||||
Net cash (used in) provide by investing activities |
11,210 | (9,032 | ) | 5,234 | (8,822 | ) | ||||||||||
Cash flows from financing activities: |
||||||||||||||||
Proceeds from exercise of stock options and employee stock purchase plan |
654 | 847 | 1,210 | 2,214 | ||||||||||||
Excess tax benefit related to stock-based compensation expense |
(999 | ) | | | | |||||||||||
Net cash provided by financing activities |
(345 | ) | 847 | 1,210 | 2,214 | |||||||||||
Net decrease in cash and cash equivalents |
(1,028 | ) | (3,305 | ) | (3,337 | ) | (113 | ) | ||||||||
Cash and cash equivalents at beginning of period |
2,951 | 10,262 | 5,260 | 7,070 | ||||||||||||
Cash and cash equivalents at end of period |
$ | 1,923 | $ | 6,957 | $ | 1,923 | $ | 6,957 | ||||||||
Supplemental and non-cash disclosure of cash flow information: |
||||||||||||||||
Change in deferred stock-based compensation, net of terminations |
$ | | $ | (118 | ) | $ | (1,255 | ) | $ | (55 | ) |
CUTERA, INC.
CONSOLIDATED REVENUE HIGHLIGHTS
(in thousands, except percentage data)
(unaudited)
Three Months Ended June 30, |
Six Months Ended June 30, | |||||||||||||||||
2006 | 2005 | Change | 2006 | 2005 | Change | |||||||||||||
Revenue By Geography: |
||||||||||||||||||
United States |
$ | 16,428 | $ | 11,415 | +44 | % | $ | 31,337 | $ | 21,795 | +44 | % | ||||||
International |
7,967 | 6,155 | +29 | % | 13,815 | 10,922 | +26 | % | ||||||||||
$ | 24,395 | $ | 17,570 | +39 | % | $ | 45,152 | $ | 32,717 | +38 | % | |||||||
Revenue By Product Category: |
||||||||||||||||||
Products |
$ | 20,311 | $ | 14,634 | +39 | % | $ | 37,867 | $ | 27,295 | +39 | % | ||||||
Product upgrades |
1,573 | 1,671 | -6 | % | 2,709 | 3,265 | -17 | % | ||||||||||
Service |
1,401 | 860 | +63 | % | 2,522 | 1,610 | +57 | % | ||||||||||
Titan refills |
1,110 | 405 | +174 | % | 2,054 | 547 | +276 | % | ||||||||||
$ | 24,395 | $ | 17,570 | +39 | % | $ | 45,152 | $ | 32,717 | +38 | % | |||||||
CUTERA, INC.
NON-GAAP RECONCILIATION OF NET INCOME AND NET INCOME PER SHARE
(in thousands, except per share data)
(unaudited)
Three Months Ended 6/30/2006 |
Six Months Ended 6/30/2006 |
|||||||
GAAP net loss |
$ | (9,049 | ) | $ | (7,942 | ) | ||
Non-GAAP adjustments to net loss |
||||||||
Litigation settlement (a) |
18,391 | 18,391 | ||||||
Income tax effect of litigation settlement (c) |
(7,114 | ) | (7,114 | ) | ||||
Stock-based compensation (b) |
911 | 1,997 | ||||||
Income tax effect of stock-based compensation (c) |
(301 | ) | (659 | ) | ||||
Total non-GAAP adjustments to net loss |
11,888 | 12,615 | ||||||
Non-GAAP net earnings |
$ | 2,839 | $ | 4,673 | ||||
GAAP diluted loss per share |
$ | (0.73 | ) | $ | (0.64 | ) | ||
Non-GAAP adjustments to diluted loss per share |
||||||||
Anti-dilutive impact of higher weighted-average shares used to compute non-GAAP diluted income per share |
0.09 | 0.08 | ||||||
Litigation settlement, net of income tax effect (a)(c) |
0.80 | 0.80 | ||||||
Stock-based compensation, net of income tax effect (b)(c) |
0.04 | 0.09 | ||||||
Non-GAAP diluted net income per share |
$ | 0.20 | $ | 0.33 | ||||
Weighted-average shares used to compute GAAP net loss per share |
12,444 | 12,352 | ||||||
Weighted-average shares used to compute non-GAAP diluted net income per share |
14,162 | 14,174 | ||||||
(a) | Litigation settlement expense incurred in June 2006. |
(b) | Non-cash stock-based compensation charges recorded in accordance with SFAS 123 (R) with effect from January 1, 2006. |
(c) | Reduced tax benefit at the marginal tax impact of excluding the litigation expense and the stock based compensation expense. |
CUTERA, INC.
NON-GAAP RECONCILIATION OF GUIDANCE NET INCOME AND NET INCOME PER SHARE
(in thousands, except per share data)
(unaudited)
Three Months Ended 9/30/2006 |
Year Ended 12/31/2006 |
|||||||
Guidance GAAP net income |
$ | 3,070 | $ | | ||||
Non-GAAP adjustments to net income |
||||||||
Litigation settlement (a) |
18,391 | |||||||
Income tax effect of litigation settlement (c) |
(7,114 | ) | ||||||
Stock-based compensation (b) |
1,250 | 4,500 | ||||||
Income tax effect of stock-based compensation (c) |
(413 | ) | (1,485 | ) | ||||
Total non-GAAP adjustments to net income |
838 | 14,292 | ||||||
Guidance Non-GAAP net income |
$ | 3,908 | $ | 14,292 | ||||
Guidance GAAP diluted net income per share |
$ | 0.21 | $ | | ||||
Non-GAAP adjustments to GAAP diluted net income per share |
||||||||
Litigation settlement, net of income tax effect (a) |
| 0.79 | ||||||
Stock-based compensation, net of income tax effect (b)(c) |
0.06 | 0.21 | ||||||
Guidance Non-GAAP diluted net income per share |
$ | 0.27 | $ | 1.00 | ||||
Weighted-average shares used to compute both GAAP and non-GAAP diluted net income per share |
14,300 | 14,260 | ||||||
(a) | Litigation settlement expense incurred in June 2006. |
(b) | Non-cash stock-based compensation charges recorded in accordance with SFAS 123 (R) with effect from January 1, 2006. |
(c) | Reduced tax benefit at the marginal tax impact of excluding the litigation expense and the stock based compensation expense. |